Aptorum Group Limited Class A Ordinary Shares
Symbol: APM (NASDAQ)
1.40
▼ (-4.11%) -0.060
Company Description:
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Key Stats
- Today's Open: $1.46
- Today's High: $1.47
- Today's Low: $1.37
- Today's Volume: 52.68K
- Yesterday Close: $1.46
- Yesterday High: $1.4699
- Yesterday Low: $1.35
- Yesterday Volume: 81.17K
- Last Min Volume: 478
- Last Min High: $1.4
- Last Min Low: $1.4
- Last Min VWAP: $1.4
Company Profile
- Name: Aptorum Group Limited Class A Ordinary Shares
- Website: https://www.aptorumgroup.com
- Listed Date: 2018-12-18
- Location: ,
- Market Status: Active
- CIK Number: 0001734005
- SIC Code:
- SIC description:
- Market Cap: $9.93M
- Round Lot: 100
- Outstanding Shares: 7.14M
- Asset Type: CS
RECENT FILINGS FOR APM
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-22 | 6-K | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-04-30 | 20-F | View |
| 2025-04-16 | 6-K | View |
| 2025-01-10 | SCHEDULE 13G | View |
| 2025-01-07 | 6-K | View |
| 2025-01-06 | SCHEDULE 13G | View |
| 2025-01-03 | 424B5 | View |
| 2024-12-20 | 6-K | View |
| 2024-12-11 | 6-K | View |
| 2024-11-08 | 6-K | View |
| 2024-11-01 | 6-K | View |
| 2024-10-25 | 6-K/A | View |
| 2024-08-09 | 6-K | View |
| 2024-07-26 | S-8 | View |
| 2024-05-31 | 6-K | View |
| 2024-04-30 | 20-F | View |
| 2024-04-30 | 6-K | View |
| 2024-04-16 | SC 13D/A | View |
| 2024-03-06 | 6-K | View |
Latest News on APM